Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed Aug 11, 2016 · 10-Q · 42 days after period end · 0001615774-16-006697
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Net Income | -$2.24M | -$4.24M | -$1.01M | -$151.92K |
| EPS Diluted | -$0.06 | -$0.22 | -$0.03 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 11, 2016 · 42 d after period end
